160 related articles for article (PubMed ID: 16507625)
1. Telbivudine: a novel nucleoside analog for chronic hepatitis B.
Kim JW; Park SH; Louie SG
Ann Pharmacother; 2006 Mar; 40(3):472-8. PubMed ID: 16507625
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis B: focus on telbivudine.
Lui YY; Chan HL
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
[TBL] [Abstract][Full Text] [Related]
3. Safety evaluation of telbivudine.
But DY; Yuen MF; Fung J; Lai CL
Expert Opin Drug Saf; 2010 Sep; 9(5):821-9. PubMed ID: 20662545
[TBL] [Abstract][Full Text] [Related]
4. Telbivudine for the management of chronic hepatitis B virus infection.
Matthews SJ
Clin Ther; 2007 Dec; 29(12):2635-53. PubMed ID: 18201580
[TBL] [Abstract][Full Text] [Related]
5. Telbivudine in the treatment of chronic hepatitis B.
Nash K
Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
[TBL] [Abstract][Full Text] [Related]
6. A review of telbivudine for the management of chronic hepatitis B virus infection.
Lui YY; Chan HL
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1351-61. PubMed ID: 18798704
[TBL] [Abstract][Full Text] [Related]
7. Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.
Han SH
Expert Opin Investig Drugs; 2005 Apr; 14(4):511-9. PubMed ID: 15882124
[TBL] [Abstract][Full Text] [Related]
8. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
Liaw YF; Gane E; Leung N; Zeuzem S; Wang Y; Lai CL; Heathcote EJ; Manns M; Bzowej N; Niu J; Han SH; Hwang SG; Cakaloglu Y; Tong MJ; Papatheodoridis G; Chen Y; Brown NA; Albanis E; Galil K; Naoumov NV;
Gastroenterology; 2009 Feb; 136(2):486-95. PubMed ID: 19027013
[TBL] [Abstract][Full Text] [Related]
9. A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.
Lai CL; Lim SG; Brown NA; Zhou XJ; Lloyd DM; Lee YM; Yuen MF; Chao GC; Myers MW
Hepatology; 2004 Sep; 40(3):719-26. PubMed ID: 15349912
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
Zhou XJ; Lim SG; Lloyd DM; Chao GC; Brown NA; Lai CL
Antimicrob Agents Chemother; 2006 Mar; 50(3):874-9. PubMed ID: 16495245
[TBL] [Abstract][Full Text] [Related]
11. Telbivudine: a new treatment for chronic hepatitis B.
Amarapurkar DN
World J Gastroenterol; 2007 Dec; 13(46):6150-5. PubMed ID: 18069753
[TBL] [Abstract][Full Text] [Related]
12. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.
Hann HW
Expert Opin Pharmacother; 2010 Sep; 11(13):2243-9. PubMed ID: 20698726
[TBL] [Abstract][Full Text] [Related]
13. Telbivudine versus lamivudine in patients with chronic hepatitis B.
Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
[TBL] [Abstract][Full Text] [Related]
14. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J
Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339
[TBL] [Abstract][Full Text] [Related]
15. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of hepatitis B infection: a brief review.
Quan DJ
Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
[TBL] [Abstract][Full Text] [Related]
17. Drug profile: telbivudine (Tyzeka).
Pham PA; Thio C
Hopkins HIV Rep; 2007 Jan; 19(1):7, 10. PubMed ID: 17569169
[No Abstract] [Full Text] [Related]
18. Telbivudine.
Keam SJ
Drugs; 2007; 67(13):1917-29. PubMed ID: 17722961
[TBL] [Abstract][Full Text] [Related]
19. Telbivudine: a new option for the treatment of chronic hepatitis B.
Ruiz-Sancho A; Sheldon J; Soriano V
Expert Opin Biol Ther; 2007 May; 7(5):751-61. PubMed ID: 17477811
[TBL] [Abstract][Full Text] [Related]
20. [New treatment of chronic hepatitis B].
Andersen ES; Weis NM
Ugeskr Laeger; 2008 Nov; 170(48):3937-9. PubMed ID: 19087730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]